These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6129169)

  • 1. Glucoregulatory mechanisms following hypophysectomy in diabetic dogs with residual insulin secretion.
    Kemmer FW; Sirek A; Sirek OV; Perez G; Vranic M
    Diabetes; 1983 Jan; 32(1):26-34. PubMed ID: 6129169
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.
    Starke A; Imamura T; Unger RH
    J Clin Invest; 1987 Jan; 79(1):20-4. PubMed ID: 2878938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central factors in the control of insulin and glucagon secretion.
    Porte D; Woods SC; Chen M; Smith PH; Ensinck JW
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
    Perez G; Kemmer FW; Lickley HL; Vranic M
    Am J Physiol; 1981 Oct; 241(4):E328-35. PubMed ID: 7032319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A super active cyclic hexapeptide analog of somatostatin.
    Veber DF; Saperstein R; Nutt RF; Freidinger RM; Brady SF; Curley P; Perlow DS; Paleveda WJ; Colton CD; Zacchei AG
    Life Sci; 1984 Apr; 34(14):1371-8. PubMed ID: 6143233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some explanations for species differences in hyperglycemic responses to adrenergic agents.
    Ellis S
    Life Sci; 1978 Apr 3-17; 22(13-15):1229-36. PubMed ID: 96312
    [No Abstract]   [Full Text] [Related]  

  • 13. Islet transplantation to the renal subcapsular space in streptozotocin-diabetic rats. Long-term effects on insulin and glucagon secretion.
    Ar'Rajab A; Ahrén B; Alumets J; Bengmark S
    Acta Chir Scand; 1989 Oct; 155(10):503-8. PubMed ID: 2513696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin release from the isolated, perfused diabetic rat pancreas: inverse relationship between pancreatic somatostatin and insulin.
    Kadowaki S; Taminato T; Chiba T; Goto Y; Nozawa M; Seino Y; Matsukura S; Fujita T
    Diabetes; 1980 Dec; 29(12):960-3. PubMed ID: 6108269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum.
    Honey RN; Schwarz JA; Mathe CJ; Weir GC
    Am J Physiol; 1980 Feb; 238(2):E150-6. PubMed ID: 6444782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and glucagon secretion in streptozotocin-diabetic rats: influences of islets transplanted to the renal subcapsular space.
    Ar'Rajab A; Ahrén B; Bengmark S
    Diabetes Res; 1989 Sep; 12(1):37-41. PubMed ID: 2517050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-induced fall in insulin: mechanism of action at the liver and effects on muscle glucose metabolism.
    Zinker BA; Mohr T; Kelly P; Namdaran K; Bracy DP; Wasserman DH
    Am J Physiol; 1994 May; 266(5 Pt 1):E683-9. PubMed ID: 7911275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in blood sugar, and insulin levels induced by somatostatin in normal, diabetic and acromegalic subjects].
    Carmina E; Lanzara P; Janní A
    Minerva Med; 1976 Apr; 67(18):1204-4-10. PubMed ID: 934480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.